Spots Global Cancer Trial Database for Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
Official Title: Personalized Circulating DNA Follow-up in Melanoma
Study ID: NCT04866680
Conditions
Interventions
Study Description
Brief Summary: PERCIMEL is an open multicentric study. The purpose of this study is to assess the interest of molecular analysis on circulating tumor DNA in the follow-up of the disease.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHU Jean Minjoz, Besançon, , France
CGFL, Dijon, , France
Chu Dijon, Dijon, , France
Chru Lille, Lille, , France
Ghr Mulhouse Sud Alsace, Mulhouse, , France
Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy, , France
Chru Nancy, Vandœuvre-lès-Nancy, , France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
